Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels

International Journal of Cardiology

Volumn 135, Issue 2, 2009, Pages 211-217

  Onat, Altan ^a,b   Özhan, Hakan ^c   Erbilen, Enver ^c   Albayrak, Sinan ^c   Küçükdurmaz, Zekeriya ^d   Can, Günay ^b   Keleş, Ibrahim ^b   Hergenç, Gülay ^e  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Cardiology Department   (Turkey)

^d GAZIANTEP UNIVERSITY   (Turkey)

^e YILDIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Central obesity; Fibrinogen; Hypertension; Inflammatory state; Insulin resistance; Metabolic syndrome

Indexed keywords

ALCOHOL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIGARETTE SMOKING; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICS; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC);

ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SMOKING; TURKEY;

EID: 67349152698     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.03.054     Document Type: Article

References (30)

1. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
2. - 455-A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease: a study of 9127 individuals based on the Copenhagen City Heart Study. J Clin Invest 99 (1997) 3034-3039
3. Krobot K., Hense H.W., Cremer P., Eberle E., and Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 12 (1992) 780-788
4. Bo M., Respo S., Morra F., Cassader M., Isaia G., and Poli L. Body fat is the main predictor of fibrinogen levels in healthy non-obese men. Metabolism 53 (2004) 984-988
5. Duncan B.B., Schmidt M.I., Chambless L.E., Folsom A.R., Carpenter M., and Heiss G. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults-the ARIC study: atherosclerosis risk in communities. Obes Res 8 (2000) 279-286
6. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294 (2005) 1799-1809
7. The ECAT Angina Pectoris Study Group Juhan-Vague I., Thompson S.G., and Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13 (1993) 1865-1873
8. Eliasson M., Evrin P.E., and Lunblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the Northern Sweden MONICA Study. J Clin Epidemiol 47 (1994) 513-524
9. Imperatore G., Riccardi G., Iovine C., Rivellese A.A., and Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. Diabetes Care 21 (1998) 649-654
10. Raynaud E., Perez-Martin A., Brun J., Aissa-Benhaddad A., Fedou C., and Mercier J. Relationships between fibrinogen and insulin resistance. Atherosclerosis 150 (2000) 365-370
11. Onat A., Ceyhan K., Başar Ö., Erer B., Toprak S., and Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 165 (2002) 285-292
12. Onat A., Avci G.S., Şenocak M., Örnek E., and Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J Epidem Commun Health 46 (1992) 470-476
13. von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17 (1957) 237-246
14. Genuth S., Alberti K.G., Bennett P., et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus: the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (2003) 3160-3167
15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
16. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
17. Onat A., Uyarel H., Hergenç G., Karabulut A., Albayrak S., and Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 191 (2007) 182-190
18. Onat A., Sari I., Hergenc G., et al. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study. Metabolism 56 (2007) 348-356
19. The Fibrinogen Studies Collaboration. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 35 (2006) 1570-1578
20. Piché M.E., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., and Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 96 (2005) 92-97
21. Onat A., Can G., and Hergenç G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 58 (2008) 207-214
22. Onat A., Ozhan H., Esen A.M., et al. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women - without associated overall health benefit. Atherosclerosis 193 (2007) 380-389
23. Shankar A., Wang J.J., Rochtchina E., and Mitchell P. Positive association between plasma fibrinogen level and incident hypertension among men: population-based cohort study. Hypertension 48 (2006) 1043-1049
24. Nascetti S., Elosua R., Pena A., Covas M.I., Senti M., and Marrugat J. For the REGICOR Investigators. Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration. Eur J Epidemiol 17 (2001) 953-958
25. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leucocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
26. Wannamethee S.G., Lowe G.D., Shaper A.G., Rumley A., Lennon L., and Whincup P.H. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 181 (2005) 101-108
27. Mora S., Rifai N., Buring J.E., and Ridker P.M. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation 114 (2006) 381-387
28. Onat A., Hergenç G., Karabulut A., Albayrak S., Can G., and Kaya Z. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Metabolism 56 (2007) 1356-1362
29. Onat A., Hergenç G., Sari{dotless} I., Karabulut A., and Can G. Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: Relative roles of insulin resistance and central obesity. Circ J 71 (2007) 1463-1467
30. Rosenson R.S., Mosca L., Staffileno B.A., and Tangney C.C. Variability in fibrinogen measurements: an obstacle to cardiovascular risk stratification. Atherosclerosis 159 (2001) 225-230